當歸、丹參萃取物對抑制癌細胞之影響--參考文獻-1 - 農業知識入口網

1. 黃光琦、袁淑蘭、周宏遠  1996  丹參酮誘導人宮頸癌ME180細胞的分化  中國藥理學與毒理學雜誌  10(4):85-289。
2. 陸欽堯、黎明  1993  丹參p.131-134  益壽中草藥  渡假出版社。
3. 顏焜熒  1985  原色生藥學 南天書局 台北。
4. Chen Q.C., J.P. Lee, W.Y. Jin, U.J. Youn, H.J. Kim, I.S. Lee, X.F. Zhang, K.S. Song, Y.H. Seong and K.H. Bae. 2007. Cytotoxic constituents from Angelica sinensis radix. Arch. Pharm. Res. 30:565-569.
5. Cheng Y.L., W.L. Chang, S.C. Lee, Y.G. Liu, C.J. Chen, S.Z. Lin, N.M. Tsai, D.S. Yu, C.Y. Yen and H.J. Harn. 2004. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci. 75:1579-1594.
6. Chor S.Y., A.Y. Hui and  K.F. To, K.K. Chan, Y.Y. Go, H.L. Chan, W.K. Leung and J.J. Sung. 2005. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. J. Ethnopharmacol. 100:180-186.
7. Circosta C., R.D. Pasquale, D.R. Palumbo, S. Samperi and F. Occhiuto. 2006. Estrogenic activity of standardized extract of Angelica sinensis. Phytother. Res. 20:665-669.
8. Du Q., B. Hu, H.M. An, K.P. Shen, L. Xu, S. Deng and M.M. Wei. 2013. SynerGIStic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol. Rep. 29:1851-1858.
9. Gu M., X. Wang, Z. Su and F. Ouyang. 2007. One-step separation and purification of 3,4-dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography. J. Chromatogr. A. 1140:107-111.
10. Hou L.L., Q. J. Xu, G.Q. Hu and S.Q. Xie. 2013. Synergistic antitumor effects of tanshinone II A in combination with cisplatin via apoptosis in the prostate cancer cells. Yao Xue Xue Bao. 48:675-679.
11. Jiang C., H.J. Lee, G.X. Li, J. Guo, B. Malewicz, Y. Zhao, E.O. Lee, H.J. Lee, J.H. Lee, M.S. Kim, S.H. Kim and J. Lu. 2006. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res. 66:453-463.
12. Kawabata K., T. Yamamoto, A. Hara, M. Shimizu, Y. Yamada, K. Matsunaga, T. Tanaka and H. Mori. 2000. Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Lett. 157:15-21.
13. Lee C.Y., H.F. Sher, H.W. Chen, C.C. Liu, C.H. Chen, C.S. Lin, P.C. Yang, H.S. Tsay and J.J. Chen. 2008. Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol. Cancer Ther. 7:3527-3538.
14. Lee H.J., H.J. Lee, E.O. Lee, J.H. Lee, K.S. Lee, K.H. Kim, S.H. Kim and J. Lu. 2009. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am. J. Chin. Med. 37:127-142.
15. Lin F.H., J.Y. Lin, R.D. Gupta, J.A Tournas, J.A. Burch, M.A. Selim, N.A. Monteiro-Riviere , J.M. Grichnik, J. Zielinski and S.R. Pinnell. 2005. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J. Invest. Dermatol. 125:826-832.
16. Lin L.,X. He, L. Lian, W. Kingand J. Elliott. 1998. Liquid chromatographic–electrospray mass spectrometric study of the phthalides of Angelica sinensis and chemical changes of Z-ligustilide. J. Chromatogr. A. 810:71-79.